Published in Eur J Epidemiol on January 01, 2005
Factors associated with adherence to anti-hypertensive treatment in Pakistan. PLoS One (2007) 1.60
Clinico-epidemiological features of hypertensive subjects in kassala town, eastern Sudan. J Family Community Med (2007) 0.78
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
Quetelet's index (W/H2) as a measure of fatness. Int J Obes (1985) 5.74
Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol (1992) 3.80
Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull (1994) 3.09
Smoking as a risk factor for cerebral ischaemia. Lancet (1989) 2.26
Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol (1996) 1.74
Physical activity and stroke risk: the Framingham Study. Am J Epidemiol (1994) 1.33
Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: the Reykjavík Study. Ann Intern Med (1999) 1.27
Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. Am J Epidemiol (1994) 1.26
Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension (1998) 1.04
Hypertension and risk of stroke recurrence. Stroke (1994) 0.87
Prevalence, awareness, treatment and control of hypertension in a working Bulgarian population. Eur J Epidemiol (2000) 0.84
Psychosocial components in stroke. Implications for adaptation. Nurs Clin North Am (1991) 0.79
A framework for the interpretation of first-order interaction in logit modeling. Psychol Bull (1991) 0.77
Measures to improve recovery in the acute phase of stroke. Cerebrovasc Dis (1999) 0.75
[Hypertension and cerebrovascular strokes]. Vnitr Lek (2001) 0.75
A preventive approach to stroke. Nurs Clin North Am (1991) 0.75
Etiology of stroke subtypes. Nurs Clin North Am (1991) 0.75
Complications in the acute stages of stroke. Nursing's pivotal role. Nurs Clin North Am (1991) 0.75
[Therapeutic non-compliance: a major problem in the prevention of cardiovascular diseases]. Rev Med Liege (1999) 0.75
Blood pressure lowering for the primary and secondary prevention of stroke: treatment of hypertension reduces the risk of stroke. J Cardiovasc Risk (1999) 0.75
Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev (2000) 0.75
Hypertension in patients presenting with stroke. Curr Hypertens Rep (2000) 0.75
Mild hypertension: to treat or not to treat. Introduction. Ann N Y Acad Sci (1978) 0.75
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia (2009) 7.06
Algebraic reconstruction techniques (ART) for three-dimensional electron microscopy and x-ray photography. J Theor Biol (1970) 6.86
Automated synthesis of gene fragments. Science (1981) 3.80
Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial. BMJ (2003) 3.35
Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication. Antimicrob Agents Chemother (1995) 2.04
Supermassive black holes do not correlate with galaxy disks or pseudobulges. Nature (2011) 1.82
Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci U S A (2001) 1.78
Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia (2005) 1.68
Application of adjusted survival curves to renal transplant data. Methods Inf Med (1992) 1.39
Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase. Virology (1994) 1.37
Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication. Antimicrob Agents Chemother (1993) 1.35
Granule cell hyperexcitability in the early post-traumatic rat dentate gyrus: the 'irritable mossy cell' hypothesis. J Physiol (2000) 1.31
A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J Clin Chem Clin Biochem (1988) 1.26
Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol (1979) 1.24
Kinetic interaction of nomifensine with a 1, 5-benzodiazepine (clobazam). Br J Clin Pharmacol (1977) 1.19
The effect of termination of membrane phospholipid synthesis on cell-dependent events in Caulobacter. J Mol Biol (1980) 1.18
Multiple test procedures other than Bonferroni's deserve wider use. BMJ (1999) 1.17
Tendamistat (HOE 467), a tight-binding alpha-amylase inhibitor from Streptomyces tendae 4158. Isolation, biochemical properties. Eur J Biochem (1984) 1.16
Smoking is associated with progression of diabetic nephropathy. Diabetes Care (1994) 1.11
Risk factors of severe hypoglycaemia in adult patients with Type I diabetes--a prospective population based study. Diabetologia (1998) 1.11
Pancreatic cancer in father and son. Lancet (1977) 1.09
A novel type of GABAergic interneuron connecting the input and the output regions of the hippocampus. J Neurosci (1997) 1.09
2-keto-3-deoxygluconate, an intermediate in the fermentation of gluconate by clostridia. J Bacteriol (1971) 1.08
Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus--a population-based study. Diabetologia (1998) 1.03
Evidence for the existence of non-GABAergic, cholinergic interneurons in the rodent hippocampus. Neuroscience (2000) 1.00
D-Gluconate dehydratase from Clostridium pasteurianum. Methods Enzymol (1982) 1.00
Longitudinal changes in energy expenditure in an elderly German population: a 12-year follow-up. Eur J Clin Nutr (2009) 0.99
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). Invest New Drugs (1994) 0.97
Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child. Diabetologia (1995) 0.97
The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip. Ann Gen Psychiatry (2006) 0.97
Logistic regression models used in medical research are poorly presented. BMJ (1996) 0.96
Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy. Diabet Med (2000) 0.96
Purification and properties of D-gluconate dehydratase from Clostridium pasteurianum. Eur J Biochem (1973) 0.94
[Survival analysis: Cox regression]. Dtsch Med Wochenschr (2007) 0.93
Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet Med (1996) 0.91
Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens (1995) 0.89
[Median or mean?]. Dtsch Med Wochenschr (2007) 0.89
[The kappa coefficient]. Dtsch Med Wochenschr (2007) 0.89
Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause (1999) 0.88
Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model. Stat Med (2010) 0.88
Effects of intensified antihypertensive treatment in diabetic nephropathy: mortality and morbidity results of a prospective controlled 10-year study. J Hypertens (1999) 0.87
The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med (1998) 0.87
Normal tissue tolerance to particle and heavy ion radiation. Arch Pathol (1973) 0.87
Prenatal diagnosis and circulatory characteristics in tetralogy of Fallot with absent pulmonary valve. Am J Cardiol (1989) 0.87
[Comparing methods of measurement]. Dtsch Med Wochenschr (2007) 0.87
The impact of discharge planning on chronic schizophrenic patients. Hosp Community Psychiatry (1984) 0.86
Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme. Diabet Med (1994) 0.85
Value of blood pressure self-monitoring as a predictor of progression of diabetic nephropathy. J Hypertens (1999) 0.85
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy. J Intern Med (2000) 0.84
Noninvasive Doppler color flow mapping for detection of anomalous origin of the left coronary artery from the pulmonary artery and for evaluation of surgical repair. J Am Coll Cardiol (1988) 0.83
Enzymatic synthesis of 2-keto-3-deoxy-d-glucose from D-gluconate. Anal Biochem (1974) 0.83
[Survival analysis: properties and Kaplan-Meier method]. Dtsch Med Wochenschr (2007) 0.82
Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia (1996) 0.82
Low prevalence of cardiac autonomic neuropathy in Type 1 diabetic patients without nephropathy. Diabet Med (2001) 0.81
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia (1996) 0.81
[Common study designs in epidemiology]. Dtsch Med Wochenschr (2007) 0.80
[Survival analysis: log rank test]. Dtsch Med Wochenschr (2007) 0.80
Fate of GABAergic septohippocampal neurons after fimbria-fornix transection as revealed by in situ hybridization for glutamate decarboxylase mRNA and parvalbumin immunocytochemistry. J Comp Neurol (1995) 0.79
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]. Diabetologia (2009) 0.78
Altered light/dark activity difference with aging in two rat strains. J Gerontol (1986) 0.78
A cross-over evaluation of different methods and devices to measure blood pressure in type 1 diabetic patients with nephropathy. Blood Press Monit (2000) 0.78
[Systematic reviews and meta-analyses]. Dtsch Med Wochenschr (2007) 0.78
ART is science being a defense of algebraic reconstruction techniques for three-dimensional electron microscopy. J Theor Biol (1971) 0.78
ART and the ribosome: a preliminary report on the three-dimensional structure of individual ribosomes determined by an algebraic reconstruction technique. J Theor Biol (1970) 0.78
Continuous-flow determination of an alpha-amylase inactivator in fermentation samples using a ferricyanide reagent. Anal Biochem (1984) 0.78
Liberalized diet in patients with type 1 diabetes. J Intern Med (1995) 0.78
Avoidance acquisition in adult and senescent rats. Gerontology (1986) 0.77
Development of cholinergic and GABAergic neurons in the rat medial septum: effect of target removal in early postnatal development. J Comp Neurol (1997) 0.77
Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence by H. Brenner and O. Gefeller, Statistics in Medicine, 16, 981-991 (1997) Stat Med (1998) 0.77
Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Diabet Med (1998) 0.76
Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy. J Intern Med (2000) 0.76
Intervention effects in the case of heterogeneity between three subgroups. Assessment within the framework of systematic reviews. Methods Inf Med (2010) 0.76
192 IgG-saporin-induced loss of cholinergic neurons in the septum abolishes cholinergic sprouting after unilateral entorhinal lesion in the rat. Eur J Neurosci (1997) 0.76
Endometrial collection and interpretation using the Tao brush and the CytoRich fixative system: a feasibility study. Diagn Cytopathol (1997) 0.76
[Is pain a clinically relevant problem in general adult psychiatry? A clinical epidemiological cross-sectional study in patients with psychiatric disorders]. Schmerz (2004) 0.75
Insufficient evaluation of adverse events is not a proof of safety. Diabetologia (2010) 0.75
Determination of the area under a curve. Diabetes Care (1994) 0.75
Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy. J Intern Med (1996) 0.75
Proton and alpha particle bombardment of mouse skin. Arch Pathol (1972) 0.75
[Aspects of sample size determination and power calculation illustrated on examples from rehabilitation research]. Rehabilitation (Stuttg) (2006) 0.75
Mortality and morbidity in treated hypertensive type 2 diabetic patients with micro- or macroproteinuria. Diabet Med (1995) 0.75
[Reaction of 2-4-aminobenzensulfonamide structures with thymol-sodium hypochlorite]. Pharmazie (2001) 0.75
Skin tolerance in rabbits to alpha particle and low energy electron irradiation. Strahlentherapie (1974) 0.75
[Acquisition of human bipedal gait from the viewpoint of the aquatic ape theory]. Anthropol Anz (1997) 0.75
[Quantiles, cumulative distribution function, and box-plot]. Dtsch Med Wochenschr (2007) 0.75
Retreat: a different approach to team building. Medsurg Nurs (1994) 0.75
[Measures of variability]. Dtsch Med Wochenschr (2007) 0.75
[The histogram]. Dtsch Med Wochenschr (2007) 0.75
Pyrido[2,3-d]pyrimidine angiotensin II antagonists. J Med Chem (1994) 0.75
Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy. Horm Metab Res (1996) 0.75
[Linear regression and correlation]. Dtsch Med Wochenschr (2007) 0.75
[What is a significance test? General issues]. Dtsch Med Wochenschr (2007) 0.75
[Equivalence and non-inferiority trials]. Dtsch Med Wochenschr (2007) 0.75
Time-action profiles of the intermediate-acting insulin analogue des(64,65)-human proinsulin. Diabete Metab (1995) 0.75
Early skeletal muscle development proceeds normally in parthenogenetic mouse embryos. Dev Biol (1994) 0.75
Early effects of monoenergetic low-energy electrons on pig skin. Arch Pathol (1970) 0.75
The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved. Diabetologia (1996) 0.75
[Is it possible to calculate minimum provider volumes for total knee replacement using routine data? Results of a threshold value analysis of German quality assurance data for inpatient treatment]. Orthopade (2007) 0.75
[Long-term studies of laboratory values]. Methods Inf Med Suppl (1976) 0.75